AstraZeneca
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Employees
- 89.9K
- Market Cap
- $270.3B
- Website
- http://www.astrazeneca.co.uk
- Introduction
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a Sulfonylurea
- Conditions
- Interventions
- First Posted Date
- 2002-06-10
- Last Posted Date
- 2015-02-24
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 377
- Registration Number
- NCT00039026
- Locations
- 🇺🇸
ANA Ventures, LLC, Mesa, Arizona, United States
🇺🇸Comprehensive Diabetes-Endocrine Medical Associates, Redwood City, California, United States
🇺🇸St. Agnes Health Care, Baltimore, Maryland, United States
Reversal of Ventricular Remodeling With Toprol-XL
- Conditions
- First Posted Date
- 2002-05-29
- Last Posted Date
- 2010-11-19
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 300
- Registration Number
- NCT00038077
- Locations
- 🇺🇸
Research Site, Farmington, Connecticut, United States
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus
- Conditions
- Interventions
- First Posted Date
- 2002-05-08
- Last Posted Date
- 2015-02-24
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 734
- Registration Number
- NCT00035984
- Locations
- 🇺🇸
Diabetes and Endocrinology Specialists, Chesterfield, Missouri, United States
🇺🇸Holston Medical Group, Kingsport, Tennessee, United States
🇺🇸University of Mississippi Medical Center, Jackson, Mississippi, United States
CAFE Comparison of Atypicals in First Episode of Psychosis
- Conditions
- First Posted Date
- 2002-05-03
- Last Posted Date
- 2013-01-04
- Lead Sponsor
- AstraZeneca
- Registration Number
- NCT00034892
- Locations
- 🇺🇸
Research Site, Dallas, Texas, United States
A Comparison of Seroquel vs. Risperidone in Schizophrenia
- Conditions
- First Posted Date
- 2002-05-03
- Last Posted Date
- 2013-01-04
- Lead Sponsor
- AstraZeneca
- Registration Number
- NCT00034905
Iressa Expanded Access Program (EAP)
- Conditions
- First Posted Date
- 2002-05-03
- Last Posted Date
- 2013-01-04
- Lead Sponsor
- AstraZeneca
- Registration Number
- NCT00034879
- Locations
- 🇺🇸
Research Site, Cheyenne, Wyoming, United States